Fusen Pharmaceutical Co., Ltd.(HK:1652)
HK$0.93-0.02 (-2.11%)
HK:1652
Fusen Pharmaceutical Co., Ltd. financials statements
HK$0.93
At close:-0.02 (-2.11%)
Want to see HK:1652 full AI Analyst Report?
Fusen Pharmaceutical Co., Ltd. (1652) Financial Statements
0 Followers
Fusen Pharmaceutical Co., Ltd. Financial Overview
Fusen Pharmaceutical Co., Ltd.'s market cap is currently ¥698.46M. The company's EPS TTM is ¥-0.00; its P/E ratio is -247.23; and it has a dividend yield of 1.15%. Fusen Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 273.37M | ¥ 326.03M | ¥ 565.61M | ¥ 491.76M | ¥ 385.66M |
| Gross Profit | ¥ 109.79M | ¥ 162.64M | ¥ 299.51M | ¥ 225.02M | ¥ 211.13M |
| Operating Income | ¥ -1.72M | ¥ -67.51M | ¥ 20.02M | ¥ 15.74M | ¥ 52.14M |
| EBITDA | ¥ 11.55M | ¥ -25.46M | ¥ 18.93M | ¥ 49.90M | ¥ 55.82M |
| Net Income | ¥ -11.78M | ¥ -188.78M | ¥ -36.28M | ¥ -34.65M | ¥ 16.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 83.88M | ¥ 21.06M | ¥ 34.85M | ¥ 128.11M | ¥ 81.70M |
| Total Assets | ¥ 1.26B | ¥ 1.24B | ¥ 1.34B | ¥ 1.35B | ¥ 1.24B |
| Total Debt | ¥ 324.34M | ¥ 383.69M | ¥ 344.12M | ¥ 228.38M | ¥ 240.69M |
| Net Debt | ¥ 240.46M | ¥ 362.64M | ¥ 309.27M | ¥ 100.28M | ¥ 159.63M |
| Total Liabilities | ¥ 891.02M | ¥ 869.80M | ¥ 781.52M | ¥ 737.38M | ¥ 582.39M |
| Stockholders' Equity | ¥ 359.40M | ¥ 369.67M | ¥ 563.52M | ¥ 614.17M | ¥ 658.17M |
| Cash Flow | |||||
| Free Cash Flow | ¥ 69.98M | ¥ 57.43M | ¥ -161.84M | ¥ 86.63M | ¥ -62.37M |
| Operating Cash Flow | ¥ 121.93M | ¥ 133.73M | ¥ -73.33M | ¥ 110.49M | ¥ 47.77M |
| Investing Cash Flow | ¥ -5.88M | ¥ -163.42M | ¥ -108.32M | ¥ -13.13M | ¥ -282.98M |
| Financing Cash Flow | ¥ -56.21M | ¥ 15.99M | ¥ 88.50M | ¥ -51.77M | ¥ 20.53M |
Currency in CNY
